These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30355740)

  • 21. Successful treatment of drug-resistant cataplexy with the anticholinergic drug tropatepine.
    Nigam M; Leu-Semenescu S; Arnulf I
    J Clin Sleep Med; 2021 Apr; 17(4):849-851. PubMed ID: 33231168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Narcolepsy Presentation in Diverse Populations: an Update.
    Spruyt K
    Curr Sleep Med Rep; 2020; 6(4):239-250. PubMed ID: 33251089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognizing and Treating Excessive Daytime Sleepiness in Patients With Narcolepsy.
    Roth T; Winkelman JW
    J Clin Psychiatry; 2020 Nov; 81(6):. PubMed ID: 33238081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression and suicidal thoughts in untreated and treated narcolepsy: Systematic analysis.
    Barateau L; Lopez R; Chenini S; Pesenti C; Rassu AL; Jaussent I; Dauvilliers Y
    Neurology; 2020 Nov; 95(20):e2755-e2768. PubMed ID: 32963102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic Hypersomnia and Other Hypersomnia Syndromes.
    Trotti LM; Arnulf I
    Neurotherapeutics; 2021 Jan; 18(1):20-31. PubMed ID: 32901432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitolisant and Other Histamine-3 Receptor Antagonists-An Update on Therapeutic Potentials and Clinical Prospects.
    Harwell V; Fasinu PS
    Medicines (Basel); 2020 Sep; 7(9):. PubMed ID: 32882898
    [No Abstract]   [Full Text] [Related]  

  • 27. Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness.
    Yoshikawa T; Nakamura T; Yanai K
    Br J Pharmacol; 2021 Feb; 178(4):750-769. PubMed ID: 32744724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropsychiatric Correlates of Narcolepsy.
    BaHammam AS; Alnakshabandi K; Pandi-Perumal SR
    Curr Psychiatry Rep; 2020 Jun; 22(8):36. PubMed ID: 32514698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of treatment on cognitive and attention problems in children with narcolepsy type 1.
    Janssens KAM; Quaedackers L; Lammers GJ; Amesz P; van Mierlo P; Aarts L; Peeters E; Hendriks D; Vandenbussche N; Overeem S; Pillen S
    Sleep; 2020 Dec; 43(12):. PubMed ID: 32505131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reply to Maski K et al. commentary on diagnosis of central disorders of hypersomnolence: Challenges in defining central disorders of hypersomnolence.
    Lammers GJ; Bassetti CLA; Dauvilliers Y
    Sleep Med Rev; 2020 Aug; 52():101326. PubMed ID: 32408090
    [No Abstract]   [Full Text] [Related]  

  • 31. Narcolepsy Severity Scale: a reliable tool assessing symptom severity and consequences.
    Dauvilliers Y; Barateau L; Lopez R; Rassu AL; Chenini S; Beziat S; Jaussent I
    Sleep; 2020 Jun; 43(6):. PubMed ID: 31993661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Mobile App for Longterm Monitoring of Narcolepsy Symptoms: Design, Development, and Evaluation.
    Quaedackers L; De Wit J; Pillen S; Van Gilst M; Batalas N; Lammers GJ; Markopoulos P; Overeem S
    JMIR Mhealth Uhealth; 2020 Jan; 8(1):e14939. PubMed ID: 31909723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological Alterations in Narcolepsy with Cataplexy and the Expression of Cognitive Deficits.
    Medrano-Martinez P; Peraita-Adrados R
    J Int Neuropsychol Soc; 2020 Jul; 26(6):587-595. PubMed ID: 31826783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 10-Year Longitudinal Observational Study Of Cataplexy In A Cohort Of Narcolepsy Type 1 Patients.
    Almeneessier AS; Alballa NS; Alsalman BH; Aleissi S; Olaish AH; BaHammam AS
    Nat Sci Sleep; 2019; 11():231-239. PubMed ID: 31695532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neurobiological basis of narcolepsy.
    Mahoney CE; Cogswell A; Koralnik IJ; Scammell TE
    Nat Rev Neurosci; 2019 Feb; 20(2):83-93. PubMed ID: 30546103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical characteristics of cataplectic attack in narcolepsy type 1.
    Huang B; Xu T; Wang Z; Chen K; Zhang J; Zhao Z; Zhuang J; Wu H
    Sleep Med; 2021 Jan; 77():261-269. PubMed ID: 31607435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.
    Mignot E; Hayduk R; Black J; Grumet FC; Guilleminault C
    Sleep; 1997 Nov; 20(11):1012-20. PubMed ID: 9456467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on narcolepsy.
    Reading PJ
    J Neurol; 2019 Jul; 266(7):1809-1815. PubMed ID: 31004212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Discrete Glycinergic Neuronal Population in the Ventromedial Medulla That Induces Muscle Atonia during REM Sleep and Cataplexy in Mice.
    Uchida S; Soya S; Saito YC; Hirano A; Koga K; Tsuda M; Abe M; Sakimura K; Sakurai T
    J Neurosci; 2021 Feb; 41(7):1582-1596. PubMed ID: 33372061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy.
    Bogan RK; Thorpy MJ; Dauvilliers Y; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Tang L; Skobieranda F; Šonka K
    Sleep; 2021 Mar; 44(3):. PubMed ID: 33184650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.